Overview

* Mativ ( MATV ) Q3 sales rise 3% yr/yr, beating analyst expectations

* Adjusted EPS for Q3 beats consensus, reflecting strong operational performance

* Adjusted EBITDA for Q3 beats analyst estimates, highest margin since 2022 merger

Outlook

* Company did not provide specific guidance for future quarters or full year in the statement

Result Drivers

* ORGANIC VOLUME INCREASES - Co attributes strong Q3 performance to higher organic volume across both segments

* PRICE MANAGEMENT - Co cites disciplined price versus input cost management as key factor in achieving highest adjusted EBITDA margin since merger

* SEGMENT SALES GROWTH - Filtration & Advanced Materials segment sales grew due to higher volume/mix and favorable currency translation, despite lower selling prices

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Sales Beat $513.70 $505 mln

mln (1

Analyst)

Q3 Beat $0.39 $0.27 (1

Adjusted Analyst)

EPS

Q3 EPS -$0.06

Q3 Beat $66.80 $65 mln

Adjusted mln (1

EBITDA Analyst)

Analyst Coverage

* The one available analyst rating on the shares is "strong buy"

* The average consensus recommendation for the commodity chemicals peer group is "buy."

* Wall Street's median 12-month price target for Mativ Holdings Inc ( MATV ) is $15.50, about 33.7% above its November 4 closing price of $10.28

* The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 8 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)